Eye imaging showdown: which device measures macular damage best?
NCT ID NCT05961332
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study compared two different eye imaging machines (Clarus and Optos) to see how well they measure geographic atrophy, a form of vision loss from age-related macular degeneration. Researchers enrolled 62 patients and took images with each device, then compared the measurements to the standard device. The goal was to find out which machine gives the most accurate results, helping doctors choose the best tool for tracking the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye imaging could reveal hidden clues to vision loss
- A new eye camera may spot stressed cells before vision loss begins
- Gene therapy injection aims to halt blinding eye disease
- Bionic eye implant aims to bring back sight in advanced macular degeneration
- New cell therapy aims to slow vision loss in retinal disease
- New pill aims to slow vision loss from dry macular degeneration